Viewing Study NCT05180851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-02-11 @ 11:08 AM
Study NCT ID: NCT05180851
Status: UNKNOWN
Last Update Posted: 2022-02-01
First Post: 2021-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study
Sponsor: Shanghai Fengxian District Central Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
None Melanoma View
None Breast Cancer View
None Bladder Cancer View
None Ovarian Carcinoma View
None Cervical Carcinoma View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer targetting gene-virotherapy(CTGVT) virus (YSCH-01) View
None Oncolytic virus View
None Oncolytic adenovirus View
None Replicative adenovirus View